ストックスクリーナーアプリを入手
34.59
4.48%
-1.6145
前日終値:
$36.20
開ける：
$35.83
24時間の取引高:
285.34K
Relative Volume:
0.30
時価総額：
$3.03B
収益：
$23.38M
当期純損益:
$-155.22M
株価収益率:
-15.79
EPS:
-2.19
ネットキャッシュフロー:
$-134.36M
1週間 パフォーマンス:
-3.52%
1か月 パフォーマンス:
-2.34%
6か月 パフォーマンス:
+46.34%
1年 パフォーマンス:
+48.48%
1日の値動き範囲:
$34.32
$36.23
1週間の範囲:
$34.32
$36.70
52週間の値動き範囲:
$13.45
$39.28
Ideaya Biosciences Inc Stock (IDYA) Company Profile
名前
Ideaya Biosciences Inc
セクター
電話
650-443-6209
住所
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA
IDYA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IDYA
Ideaya Biosciences Inc
|
34.57 | 3.17B | 23.38M | -155.22M | -134.36M | -2.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.56 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
751.87 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
816.00 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
362.87 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.26 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Ideaya Biosciences Inc Stock (IDYA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-07 | 再開されました | UBS | Buy |
| 2025-11-24 | 開始されました | Truist | Buy |
| 2025-09-18 | 開始されました | Guggenheim | Buy |
| 2025-09-04 | 開始されました | Barclays | Overweight |
| 2025-09-04 | 開始されました | Citizens JMP | Mkt Outperform |
| 2025-07-22 | 開始されました | TD Cowen | Buy |
| 2025-07-10 | 再開されました | Goldman | Neutral |
| 2025-06-26 | 開始されました | Wells Fargo | Overweight |
| 2024-11-18 | 開始されました | Stephens | Overweight |
| 2024-11-05 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-10-24 | 開始されました | UBS | Buy |
| 2024-10-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-07-08 | 開始されました | Mizuho | Outperform |
| 2024-03-08 | 開始されました | BTIG Research | Buy |
| 2023-08-08 | 開始されました | SVB Securities | Outperform |
| 2023-05-24 | 開始されました | Goldman | Buy |
| 2023-04-24 | アップグレード | Stifel | Hold → Buy |
| 2023-03-23 | 開始されました | Berenberg | Buy |
| 2023-02-28 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-12-28 | 開始されました | CapitalOne | Overweight |
| 2022-10-27 | 開始されました | Citigroup | Buy |
| 2022-08-15 | ダウングレード | Stifel | Buy → Hold |
| 2022-07-18 | 再開されました | Oppenheimer | Outperform |
| 2022-03-10 | アップグレード | Stifel | Hold → Buy |
| 2021-09-23 | 開始されました | Stifel | Hold |
| 2021-06-04 | 再開されました | Robert W. Baird | Outperform |
| 2021-03-11 | 開始されました | Guggenheim | Buy |
| 2020-10-07 | 開始されました | Wedbush | Outperform |
| 2020-09-01 | 開始されました | Northland Capital | Outperform |
| 2020-07-13 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-06-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-04-06 | 開始されました | H.C. Wainwright | Buy |
| 2020-03-13 | 開始されました | ROTH Capital | Buy |
| 2019-10-17 | 開始されました | Oppenheimer | Outperform |
| 2019-09-10 | 開始されました | Robert W. Baird | Outperform |
| 2019-06-17 | 開始されました | Citigroup | Buy |
| 2019-06-17 | 開始されました | JP Morgan | Neutral |
| 2019-06-17 | 開始されました | Jefferies | Buy |
すべてを表示
Ideaya Biosciences Inc (IDYA) 最新ニュース
Why (IDYA) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Sectors Review: Whats the beta of IDEAYA Biosciences Inc stockJuly 2025 News Drivers & AI Powered Trade Plan Recommendations - baoquankhu1.vn
RBC Raises Price Target on IDEAYA Biosciences to $45 From $41, Keeps Outperform, Speculative Risk - marketscreener.com
Winners Losers: Is IDEAYA Biosciences Inc subject to activist investor interestQuarterly Market Summary & AI Driven Stock Reports - baoquankhu1.vn
Ideaya Biosciences advances with IDE892 study targeting MTAP-deleted tumors - MSN
IDEAYA Biosciences, Inc. $IDYA Stake Lifted by SG Americas Securities LLC - MarketBeat
FEDERATED HERMES, INC. Reduces Stake in IDEAYA Biosciences Inc - GuruFocus
IDEAYA Biosciences (IDYA) Stock Analysis: A Biotech Gem With A Potential 34.92% Upside - DirectorsTalk Interviews
Analysts Offer Insights on Healthcare Companies: Medline, Inc. Class A (MDLN) and IDEAYA Biosciences (IDYA) - The Globe and Mail
Understanding Momentum Shifts in (IDYA) - Stock Traders Daily
IDEAYA Biosciences Outlines 2026 Corporate Objectives and Clinical Progress - Intellectia AI
IDEAYA Biosciences Updates 2026 Corporate Objectives at J.P. Morgan Conference - Intellectia AI
New cancer trials aim to save vision and extend lives in rare eye cancer - Stock Titan
IDEAYA Biosciences Provides a Business Update and Outlines 2026 Corporate Objectives at the 44th Annual J.P. Morgan Healthcare Conference | IDYA Stock News - Longbridge
IDEAYA Biosciences Provides a Business Update and Outlines 2026 Corporate Objectives at the 44th Annual J.P. Morgan Healthcare Conference - PR Newswire
IDEAYA Biosciences Updates 2026 Strategic Objectives, Plans to Advance Four Registrational Trials - Intellectia AI
Why IDEAYA Biosciences Inc. stock attracts global investors2025 Market Overview & Safe Capital Growth Stock Tips - ulpravda.ru
How buybacks impact IDEAYA Biosciences Inc. stock valueWeekly Risk Summary & Fast Gain Stock Trading Tips - Улправда
Why IDEAYA Biosciences Inc. stock is considered a top pickFit and Size Notes & walk-ready comfort choices - Улправда
GSK ends collaboration with IDEAYA for two candidates - MSN
Earnings Recap: How analysts rate IDEAYA Biosciences Inc. stock todayTake Profit & Safe Capital Growth Tips - Улправда
Why IDEAYA Biosciences Inc. stock remains on buy listsJuly 2025 Short Interest & Smart Money Movement Tracker - Улправда
What downside risks could hit IDEAYA Biosciences Inc. (30J) stockQuarterly Portfolio Review & Verified Entry Point Detection - Улправда
Ideaya Biosciences stock hits 52-week high at 37.09 USD By Investing.com - Investing.com Nigeria
IDEAYA Biosciences (NASDAQ:IDYA) Sets New 12-Month HighStill a Buy? - MarketBeat
IDEAYA Biosciences (NASDAQ:IDYA) Coverage Initiated at UBS Group - MarketBeat
Ideaya Biosciences stock hits 52-week high at 37.09 USD - Investing.com
Ideaya Biosciences stock gets Buy rating from UBS with $50 price target - Investing.com Canada
Will IDEAYA Biosciences Inc. stock rally after Fed decisions2026 world cup usa national team group stage star players high defensive line odds analysis guide - Улправда
Will IDEAYA Biosciences Inc. stock outperform growth indexes2026 world cup usa national team third place match goalkeepers possession football group prediction preview - ulpravda.ru
Truist Securities raises Ideaya Biosciences stock price target to $60 By Investing.com - Investing.com Canada
IDEAYA Biosciences Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference | IDYA Stock News - Longbridge
IDEAYA Biosciences Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference - Barchart.com
IDEAYA Biosciences Completes Targeted Full Enrollment in Randomized Pivotal Phase 2/3 Trial (OptimUM-02) of Darovasertib in Combination with Crizotinib in First-line HLA*A2-Negative Metastatic Uveal Melanoma - Quantisnow
Buyback Watch: Can IDEAYA Biosciences Inc 30J stock ride next bull market cycleJuly 2025 Movers & AI Powered Trade Plan Recommendations - moha.gov.vn
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
IDEAYA Biosciences (NASDAQ:IDYA) Nasdaq 100 Index Research-Driven Model - Kalkine Media
Avoiding Lag: Real-Time Signals in (IDYA) Movement - Stock Traders Daily
IDEAYA Biosciences Sees Unusually Large Options Volume (NASDAQ:IDYA) - MarketBeat
Will IDEAYA Biosciences Inc. stock benefit from commodity pricesCandlestick Trading Patterns & Next-Level Stock Intelligence, Now Free - bollywoodhelpline.com
IDEAYA Biosciences Earnings Notes - Trefis
Squarepoint Ops LLC Sells 51,937 Shares of IDEAYA Biosciences, Inc. $IDYA - MarketBeat
Biotech Stocks Shine After Hours: Novo Nordisk, IDEAYA, Healthcare Triangle Among Gainers - Nasdaq
Technical Reactions to IDYA Trends in Macro Strategies - Stock Traders Daily
How IDEAYA Biosciences Inc. (30J) stock compares with tech leaders2025 Technical Patterns & Community Supported Trade Ideas - Улправда
Why IDEAYA Biosciences Inc. stock attracts high net worth investorsJuly 2025 Price Swings & Weekly High Return Stock Opportunities - Улправда
Aug EndMonth: Why IDEAYA Biosciences Inc. stock attracts high net worth investorsStock Surge & Accurate Trade Setup Notifications - Улправда
Why IDEAYA Biosciences Inc. stock appeals to dividend seekersQuarterly Profit Summary & Precise Swing Trade Alerts - Улправда
How interest rate cuts could boost IDEAYA Biosciences Inc. stockChart Signals & Consistent Return Investment Signals - Улправда
Gap Down: Will IDEAYA Biosciences Inc. stock outperform growth indexesJuly 2025 Update & Expert-Curated Trade Recommendations - Улправда
Why IDEAYA Biosciences Inc. (30J) stock remains top ratedPortfolio Return Summary & AI Powered Buy and Sell Recommendations - DonanımHaber
Ideaya Biosciences Inc (IDYA) 財務データ
収益
当期純利益
現金流量
EPS
3.31%
2.06%
大文字化:
|
ボリューム (24 時間):